English

ANGIOTECH PHARMACEUTICALS INC

EDGAR

Annual report (10-K) · filed 2013-03-28

32 filing records in this dataset, filed from 2003-03-06 to 2013-03-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

57.5 million USD

2012 Q4 · USD

Exact inputs and evidence

Revenue: 221326000 USD Source
Revenue: 163808000 USD Source

Operating margin

15.01%

2012 Q4 · %

Exact inputs and evidence

Operating Income: 26803000 USD Source
Operating Income: 18169000 USD Source
Revenue: 221326000 USD Source
Revenue: 163808000 USD Source

Operating cash flow

27.6 million USD

2012 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 66432000 USD Source
Operating Cash Flow: 38882000 USD Source

Free cash flow

26.7 million USD

2012 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 66432000 USD Source
Operating Cash Flow: 38882000 USD Source
Capital Expenditure: 2115000 USD Source
Capital Expenditure: 1296000 USD Source

Cash and cash equivalents: 45.9 million USD 2012-12-31 Source
Exact value

45945000 USD
Long-term debt including current maturities: 289 million USD 2012-12-31 Source
Exact value

289437000 USD
Shares outstanding: 12.5 million shares 2012-12-31 Source
Exact value

12547702 shares

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

230 million USD

2012-01-01 – 2012-12-31

Exact inputs and evidence

Revenue: 54623000 USD · 2012-01-01 – 2012-03-31 Source
Revenue: 61338000 USD · 2012-04-01 – 2012-06-30 Source
Revenue: 56637000 USD · 2012-07-01 – 2012-09-30 Source
Revenue: 221326000 USD · 2012-01-01 – 2012-12-31 Source
Revenue: 163808000 USD · 2012-01-01 – 2012-09-30 Source

Net income

-78.1 million USD

2010-04-01 – 2011-03-31

Exact inputs and evidence

Net income: -14074000 USD · 2010-04-01 – 2010-06-30 Source
Net income: -18500000 USD · 2010-07-01 – 2010-09-30 Source
Net income: -66811000 USD · 2010-01-01 – 2010-12-31 Source
Net income: -39269000 USD · 2010-01-01 – 2010-09-30 Source
Net income: -18001000 USD · 2011-01-01 – 2011-03-31 Source

Operating cash flow

66.4 million USD

2012-01-01 – 2012-12-31

Exact inputs and evidence

Operating cash flow: 11871000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 23361000 USD · 2012-04-01 – 2012-06-30 Source
Operating cash flow: 3651000 USD · 2012-07-01 – 2012-09-30 Source
Operating cash flow: 66432000 USD · 2012-01-01 – 2012-12-31 Source
Operating cash flow: 38882000 USD · 2012-01-01 – 2012-09-30 Source

Capital expenditure

2.12 million USD

2012-01-01 – 2012-12-31

Exact inputs and evidence

Capital expenditure: 413000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 436000 USD · 2012-04-01 – 2012-06-30 Source
Capital expenditure: 447000 USD · 2012-07-01 – 2012-09-30 Source
Capital expenditure: 2115000 USD · 2012-01-01 – 2012-12-31 Source
Capital expenditure: 1296000 USD · 2012-01-01 – 2012-09-30 Source

Free cash flow

64.3 million USD

2012-01-01 – 2012-12-31

Exact inputs and evidence

Operating cash flow: 11871000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 23361000 USD · 2012-04-01 – 2012-06-30 Source
Operating cash flow: 3651000 USD · 2012-07-01 – 2012-09-30 Source
Operating cash flow: 66432000 USD · 2012-01-01 – 2012-12-31 Source
Operating cash flow: 38882000 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 413000 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 436000 USD · 2012-04-01 – 2012-06-30 Source
Capital expenditure: 447000 USD · 2012-07-01 – 2012-09-30 Source
Capital expenditure: 2115000 USD · 2012-01-01 – 2012-12-31 Source
Capital expenditure: 1296000 USD · 2012-01-01 – 2012-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-03-28.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2012-12-31
Operating income: 11 of 11 periods available· newest 2012-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 11 of 11 periods available· newest 2012-12-31
Capital expenditure: 11 of 11 periods available· newest 2012-12-31
Total assets: 7 of 11 periods available· newest 2012-12-31
liabilities: No compatible figures in this window
Current assets: 7 of 11 periods available· newest 2012-12-31
Current liabilities: 7 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2012-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2012-12-31
Shares outstanding: 1 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue USD 221.33 million 100% of revenue
Cost of revenue USD 102.71 million 46% of revenue
Operating expenses USD 78.04 million 35% of revenue
Other operating costs Derived USD 13.78 million 6.2% of revenue
Operating income USD 26.8 million 12% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow USD 66.43 million 30% of revenue
Capital expenditure USD 2.12 million 1% of revenue
Free cash flow Derived USD 64.32 million 29% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2007 15%82%
2007 Operating loss: operating costs were 107% of revenue.
2008 Operating loss: operating costs were 107% of revenue.
2008 Operating loss: operating costs were 107% of revenue.
2008 Operating loss: operating costs were 337% of revenue.
2009 Operating loss: operating costs were 107% of revenue.
2009 Operating loss: operating costs were 107% of revenue.
2009 Net loss: net income was −8.2% of revenue.
2010 Operating loss: operating costs were 108% of revenue.
2012 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2007 2006-03-24 – 2007-03-23	315075000	256911000 Derived	58164000	47450000 Derived	10714000	45020000 Derived	Source 2006-03-24 – 2007-03-23: 315075000 USD Inspect Revenue Open source 2006-03-24 – 2007-03-23: 58164000 USD Inspect Operating Income Open source 2006-03-24 – 2007-03-23: 10714000 USD Inspect Net Income Open source 2006-03-24 – 2007-03-23: 55871000 USD Inspect Operating Cash Flow Open source 2006-03-24 – 2007-03-23: 10851000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	287694000	308433000 Derived	-20739000	45201000 Derived	-65940000	-12693000 Derived	Source 2007-01-01 – 2007-12-31: 287694000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -20739000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -65940000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -5562000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 7131000 USD Inspect Capital Expenditure Open source
2008 2007-03-14 – 2008-03-13	287694000	308433000 Derived	-20739000	45201000 Derived	-65940000	-12693000 Derived	Source 2007-03-14 – 2008-03-13: 287694000 USD Inspect Revenue Open source 2007-03-14 – 2008-03-13: -20739000 USD Inspect Operating Income Open source 2007-03-14 – 2008-03-13: -65940000 USD Inspect Net Income Open source 2007-03-14 – 2008-03-13: -5562000 USD Inspect Operating Cash Flow Open source 2007-03-14 – 2008-03-13: 7131000 USD Inspect Capital Expenditure Open source
2008 2007-03-24 – 2008-03-23	287694000	308433000 Derived	-20739000	45201000 Derived	-65940000	-12693000 Derived	Source 2007-03-24 – 2008-03-23: 287694000 USD Inspect Revenue Open source 2007-03-24 – 2008-03-23: -20739000 USD Inspect Operating Income Open source 2007-03-24 – 2008-03-23: -65940000 USD Inspect Net Income Open source 2007-03-24 – 2008-03-23: -5562000 USD Inspect Operating Cash Flow Open source 2007-03-24 – 2008-03-23: 7131000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	283272000	954451000 Derived	-671179000	69997000 Derived	-741176000	-45676000 Derived	Source 2008-01-01 – 2008-12-31: 283272000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -671179000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -741176000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -38007000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 7669000 USD Inspect Capital Expenditure Open source
2009 2008-03-14 – 2009-03-13	283272000	303483000 Derived	-20211000	720965000 Derived	-741176000	-45676000 Derived	Source 2008-03-14 – 2009-03-13: 283272000 USD Inspect Revenue Open source 2008-03-14 – 2009-03-13: -20211000 USD Inspect Operating Income Open source 2008-03-14 – 2009-03-13: -741176000 USD Inspect Net Income Open source 2008-03-14 – 2009-03-13: -38007000 USD Inspect Operating Cash Flow Open source 2008-03-14 – 2009-03-13: 7669000 USD Inspect Capital Expenditure Open source
2009 2008-03-24 – 2009-03-23	283272000	303483000 Derived	-20211000	720965000 Derived	-741176000	-45676000 Derived	Source 2008-03-24 – 2009-03-23: 283272000 USD Inspect Revenue Open source 2008-03-24 – 2009-03-23: -20211000 USD Inspect Operating Income Open source 2008-03-24 – 2009-03-23: -741176000 USD Inspect Net Income Open source 2008-03-24 – 2009-03-23: -38007000 USD Inspect Operating Cash Flow Open source 2008-03-24 – 2009-03-23: 7669000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	279678000	256593000 Derived	23085000	45953000 Derived	-22868000	17605000 Derived	Source 2009-01-01 – 2009-12-31: 279678000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 23085000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -22868000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 21971000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 4366000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	246242000	266299000 Derived	-20057000	46754000 Derived	-66811000	-27335000 Derived	Source 2010-01-01 – 2010-12-31: 246242000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -20057000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -66811000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -21609000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 5726000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	221326000	194523000 Derived	26803000	Unavailable	Unavailable	64317000 Derived	Source 2012-01-01 – 2012-12-31: 221326000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 26803000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 66432000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 2115000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 221.3M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-03-23	Revenue	315075000	Revenue: 315075000 Open source
20072007-12-31	Revenue	287694000	Revenue: 287694000 Open source
20082008-03-13	Revenue	287694000	Revenue: 287694000 Open source
20082008-03-23	Revenue	287694000	Revenue: 287694000 Open source
20082008-12-31	Revenue	283272000	Revenue: 283272000 Open source
20092009-03-13	Revenue	283272000	Revenue: 283272000 Open source
20092009-03-23	Revenue	283272000	Revenue: 283272000 Open source
20092009-12-31	Revenue	279678000	Revenue: 279678000 Open source
20102010-12-31	Revenue	246242000	Revenue: 246242000 Open source
20122012-12-31	Revenue	221326000	Revenue: 221326000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-12% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20072007-03-23	Year over year	No prior comparable period	Revenue: 315075000 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 287694000 Open source
20082008-03-13	Year over year	-8.7%	Revenue: 287694000 Open source Revenue: 315075000 Open source
20082008-03-23	Year over year	-8.7%	Revenue: 287694000 Open source Revenue: 315075000 Open source
20082008-12-31	Year over year	-1.5%	Revenue: 283272000 Open source Revenue: 287694000 Open source
20092009-03-13	Year over year	-1.5%	Revenue: 283272000 Open source Revenue: 287694000 Open source
20092009-03-23	Year over year	-1.5%	Revenue: 283272000 Open source Revenue: 287694000 Open source
20092009-12-31	Year over year	-1.3%	Revenue: 279678000 Open source Revenue: 283272000 Open source
20102010-12-31	Year over year	-12%	Revenue: 246242000 Open source Revenue: 279678000 Open source
20122012-12-31	Year over year	No prior comparable period	Revenue: 221326000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 12.1% 2012

Net margin -27.1% 2010

Free cash flow margin 29.1% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20072007-03-23	Operating margin	18.5%	Operating Income: 58164000 Open source Revenue: 315075000 Open source
20072007-12-31	Operating margin	-7.2%	Operating Income: -20739000 Open source Revenue: 287694000 Open source
20082008-03-13	Operating margin	-7.2%	Operating Income: -20739000 Open source Revenue: 287694000 Open source
20082008-03-23	Operating margin	-7.2%	Operating Income: -20739000 Open source Revenue: 287694000 Open source
20082008-12-31	Operating margin	-236.9%	Operating Income: -671179000 Open source Revenue: 283272000 Open source
20092009-03-13	Operating margin	-7.1%	Operating Income: -20211000 Open source Revenue: 283272000 Open source
20092009-03-23	Operating margin	-7.1%	Operating Income: -20211000 Open source Revenue: 283272000 Open source
20092009-12-31	Operating margin	8.3%	Operating Income: 23085000 Open source Revenue: 279678000 Open source
20102010-12-31	Operating margin	-8.1%	Operating Income: -20057000 Open source Revenue: 246242000 Open source
20122012-12-31	Operating margin	12.1%	Operating Income: 26803000 Open source Revenue: 221326000 Open source
20072007-03-23	Net margin	3.4%	Net Income: 10714000 Open source Revenue: 315075000 Open source
20072007-12-31	Net margin	-22.9%	Net Income: -65940000 Open source Revenue: 287694000 Open source
20082008-03-13	Net margin	-22.9%	Net Income: -65940000 Open source Revenue: 287694000 Open source
20082008-03-23	Net margin	-22.9%	Net Income: -65940000 Open source Revenue: 287694000 Open source
20082008-12-31	Net margin	-261.6%	Net Income: -741176000 Open source Revenue: 283272000 Open source
20092009-03-13	Net margin	-261.6%	Net Income: -741176000 Open source Revenue: 283272000 Open source
20092009-03-23	Net margin	-261.6%	Net Income: -741176000 Open source Revenue: 283272000 Open source
20092009-12-31	Net margin	-8.2%	Net Income: -22868000 Open source Revenue: 279678000 Open source
20102010-12-31	Net margin	-27.1%	Net Income: -66811000 Open source Revenue: 246242000 Open source
2012-12-31	Net margin	Not reported	Revenue: 221326000 Open source
20072007-03-23	Free cash flow margin	14.3%	Revenue: 315075000 Open source Operating Cash Flow: 55871000 Open source Capital Expenditure: 10851000 Open source
20072007-12-31	Free cash flow margin	-4.4%	Revenue: 287694000 Open source Operating Cash Flow: -5562000 Open source Capital Expenditure: 7131000 Open source
20082008-03-13	Free cash flow margin	-4.4%	Revenue: 287694000 Open source Operating Cash Flow: -5562000 Open source Capital Expenditure: 7131000 Open source
20082008-03-23	Free cash flow margin	-4.4%	Revenue: 287694000 Open source Operating Cash Flow: -5562000 Open source Capital Expenditure: 7131000 Open source
20082008-12-31	Free cash flow margin	-16.1%	Revenue: 283272000 Open source Operating Cash Flow: -38007000 Open source Capital Expenditure: 7669000 Open source
20092009-03-13	Free cash flow margin	-16.1%	Revenue: 283272000 Open source Operating Cash Flow: -38007000 Open source Capital Expenditure: 7669000 Open source
20092009-03-23	Free cash flow margin	-16.1%	Revenue: 283272000 Open source Operating Cash Flow: -38007000 Open source Capital Expenditure: 7669000 Open source
20092009-12-31	Free cash flow margin	6.3%	Revenue: 279678000 Open source Operating Cash Flow: 21971000 Open source Capital Expenditure: 4366000 Open source
20102010-12-31	Free cash flow margin	-11.1%	Revenue: 246242000 Open source Operating Cash Flow: -21609000 Open source Capital Expenditure: 5726000 Open source
20122012-12-31	Free cash flow margin	29.1%	Revenue: 221326000 Open source Operating Cash Flow: 66432000 Open source Capital Expenditure: 2115000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 66.4M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-03-23	Operating cash flow	55871000	Operating Cash Flow: 55871000 Open source
20072007-12-31	Operating cash flow	-5562000	Operating Cash Flow: -5562000 Open source
20082008-03-13	Operating cash flow	-5562000	Operating Cash Flow: -5562000 Open source
20082008-03-23	Operating cash flow	-5562000	Operating Cash Flow: -5562000 Open source
20082008-12-31	Operating cash flow	-38007000	Operating Cash Flow: -38007000 Open source
20092009-03-13	Operating cash flow	-38007000	Operating Cash Flow: -38007000 Open source
20092009-03-23	Operating cash flow	-38007000	Operating Cash Flow: -38007000 Open source
20092009-12-31	Operating cash flow	21971000	Operating Cash Flow: 21971000 Open source
20102010-12-31	Operating cash flow	-21609000	Operating Cash Flow: -21609000 Open source
20122012-12-31	Operating cash flow	66432000	Operating Cash Flow: 66432000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 64.3M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-03-23	Free cash flow	45020000	Operating Cash Flow: 55871000 Open source Capital Expenditure: 10851000 Open source
20072007-12-31	Free cash flow	-12693000	Operating Cash Flow: -5562000 Open source Capital Expenditure: 7131000 Open source
20082008-03-13	Free cash flow	-12693000	Operating Cash Flow: -5562000 Open source Capital Expenditure: 7131000 Open source
20082008-03-23	Free cash flow	-12693000	Operating Cash Flow: -5562000 Open source Capital Expenditure: 7131000 Open source
20082008-12-31	Free cash flow	-45676000	Operating Cash Flow: -38007000 Open source Capital Expenditure: 7669000 Open source
20092009-03-13	Free cash flow	-45676000	Operating Cash Flow: -38007000 Open source Capital Expenditure: 7669000 Open source
20092009-03-23	Free cash flow	-45676000	Operating Cash Flow: -38007000 Open source Capital Expenditure: 7669000 Open source
20092009-12-31	Free cash flow	17605000	Operating Cash Flow: 21971000 Open source Capital Expenditure: 4366000 Open source
20102010-12-31	Free cash flow	-27335000	Operating Cash Flow: -21609000 Open source Capital Expenditure: 5726000 Open source
20122012-12-31	Free cash flow	64317000	Operating Cash Flow: 66432000 Open source Capital Expenditure: 2115000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2007-03-23	Liabilities / assets	Not reported	No source recorded
2007-12-31	Liabilities / assets	Not reported	Total Assets: 1150108000 Open source
2008-03-13	Liabilities / assets	Not reported	No source recorded
2008-03-23	Liabilities / assets	Not reported	No source recorded
2008-12-31	Liabilities / assets	Not reported	Total Assets: 385197000 Open source
2009-03-13	Liabilities / assets	Not reported	Total Assets: 385197000 Open source
2009-03-23	Liabilities / assets	Not reported	Total Assets: 385197000 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 370059000 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 305998000 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 608402000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.19× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2007-03-23	Current assets / current liabilities	Not reported	No source recorded
20072007-12-31	Current assets / current liabilities	2.84×	Current Assets: 178584000 Open source Current Liabilities: 62940000 Open source
2008-03-13	Current assets / current liabilities	Not reported	No source recorded
2008-03-23	Current assets / current liabilities	Not reported	No source recorded
20082008-12-31	Current assets / current liabilities	1.85×	Current Assets: 112972000 Open source Current Liabilities: 61205000 Open source
20092009-03-13	Current assets / current liabilities	1.84×	Current Assets: 112972000 Open source Current Liabilities: 61415000 Open source
20092009-03-23	Current assets / current liabilities	1.84×	Current Assets: 112972000 Open source Current Liabilities: 61415000 Open source
20092009-12-31	Current assets / current liabilities	2.05×	Current Assets: 129698000 Open source Current Liabilities: 63186000 Open source
20102010-12-31	Current assets / current liabilities	0.19×	Current Assets: 121124000 Open source Current Liabilities: 639863000 Open source
20122012-12-31	Current assets / current liabilities	1.19×	Current Assets: 136411000 Open source Current Liabilities: 114355000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2006-03-24 – 2007-03-23	USD 10.71 million Exact value Exact value: 10714000 USD 2006-03-24 – 2007-03-23: 10714000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2007-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: 10714000 USD Concept: fundies:NetIncome Period: 2006-03-24 to 2007-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2007-03-23&surface=latest&period_type=duration&start=2006-03-24&unit=USD&dimensions= Input fundies:NetIncome: 10714000 USD (2006-03-24 to 2007-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2659 The citation records this snapshot. The page link may show a newer release later.	USD 55.87 million Exact value Exact value: 55871000 USD 2006-03-24 – 2007-03-23: 55871000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2007-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: 55871000 USD Concept: fundies:OperatingCashFlow Period: 2006-03-24 to 2007-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2007-03-23&surface=latest&period_type=duration&start=2006-03-24&unit=USD&dimensions= Input fundies:OperatingCashFlow: 55871000 USD (2006-03-24 to 2007-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2887 The citation records this snapshot. The page link may show a newer release later.	USD 10.85 million Exact value Exact value: 10851000 USD 2006-03-24 – 2007-03-23: 10851000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2007-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 10851000 USD Concept: fundies:CapitalExpenditure Period: 2006-03-24 to 2007-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2007-03-23&surface=latest&period_type=duration&start=2006-03-24&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10851000 USD (2006-03-24 to 2007-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2962 The citation records this snapshot. The page link may show a newer release later.	USD 45.02 million Calculation and evidence 55871000 − 10851000 USD Exact free cash flow: 45020000 USD 2006-03-24 – 2007-03-23: 55871000 USD · Inspect Operating Cash Flow · Source 2006-03-24 – 2007-03-23: 10851000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2007-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: 45020000 USD Concept: free-cash-flow Period: 2006-03-24 to 2007-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 55871000 USD (2006-03-24 to 2007-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2887 Input fundies:CapitalExpenditure: 10851000 USD (2006-03-24 to 2007-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2962 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 65.94 million Exact value Exact value: -65940000 USD 2007-01-01 – 2007-12-31: -65940000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2007-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: -65940000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65940000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-10-058537.txt#10134 The citation records this snapshot. The page link may show a newer release later.	−USD 5.56 million Exact value Exact value: -5562000 USD 2007-01-01 – 2007-12-31: -5562000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2007-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: -5562000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5562000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-10-058537.txt#10372 The citation records this snapshot. The page link may show a newer release later.	USD 7.13 million Exact value Exact value: 7131000 USD 2007-01-01 – 2007-12-31: 7131000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2007-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 7131000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7131000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-10-058537.txt#10456 The citation records this snapshot. The page link may show a newer release later.	−USD 12.69 million Calculation and evidence -5562000 − 7131000 USD Exact free cash flow: -12693000 USD 2007-01-01 – 2007-12-31: -5562000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 7131000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2007-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: -12693000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5562000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-10-058537.txt#10372 Input fundies:CapitalExpenditure: 7131000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-10-058537.txt#10456 The citation records this snapshot. The page link may show a newer release later.
2008 2007-03-14 – 2008-03-13	−USD 65.94 million Exact value Exact value: -65940000 USD 2007-03-14 – 2008-03-13: -65940000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2008-03-13 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: -65940000 USD Concept: fundies:NetIncome Period: 2007-03-14 to 2008-03-13 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2008-03-13&surface=latest&period_type=duration&start=2007-03-14&unit=USD&dimensions= Input fundies:NetIncome: -65940000 USD (2007-03-14 to 2008-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34259 The citation records this snapshot. The page link may show a newer release later.	−USD 5.56 million Exact value Exact value: -5562000 USD 2007-03-14 – 2008-03-13: -5562000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2008-03-13 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: -5562000 USD Concept: fundies:OperatingCashFlow Period: 2007-03-14 to 2008-03-13 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2008-03-13&surface=latest&period_type=duration&start=2007-03-14&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5562000 USD (2007-03-14 to 2008-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34487 The citation records this snapshot. The page link may show a newer release later.	USD 7.13 million Exact value Exact value: 7131000 USD 2007-03-14 – 2008-03-13: 7131000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2008-03-13 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 7131000 USD Concept: fundies:CapitalExpenditure Period: 2007-03-14 to 2008-03-13 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2008-03-13&surface=latest&period_type=duration&start=2007-03-14&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7131000 USD (2007-03-14 to 2008-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34562 The citation records this snapshot. The page link may show a newer release later.	−USD 12.69 million Calculation and evidence -5562000 − 7131000 USD Exact free cash flow: -12693000 USD 2007-03-14 – 2008-03-13: -5562000 USD · Inspect Operating Cash Flow · Source 2007-03-14 – 2008-03-13: 7131000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2008-03-13 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: -12693000 USD Concept: free-cash-flow Period: 2007-03-14 to 2008-03-13 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5562000 USD (2007-03-14 to 2008-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34487 Input fundies:CapitalExpenditure: 7131000 USD (2007-03-14 to 2008-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34562 The citation records this snapshot. The page link may show a newer release later.
2008 2007-03-24 – 2008-03-23	−USD 65.94 million Exact value Exact value: -65940000 USD 2007-03-24 – 2008-03-23: -65940000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2008-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: -65940000 USD Concept: fundies:NetIncome Period: 2007-03-24 to 2008-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2008-03-23&surface=latest&period_type=duration&start=2007-03-24&unit=USD&dimensions= Input fundies:NetIncome: -65940000 USD (2007-03-24 to 2008-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2659 The citation records this snapshot. The page link may show a newer release later.	−USD 5.56 million Exact value Exact value: -5562000 USD 2007-03-24 – 2008-03-23: -5562000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2008-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: -5562000 USD Concept: fundies:OperatingCashFlow Period: 2007-03-24 to 2008-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2008-03-23&surface=latest&period_type=duration&start=2007-03-24&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5562000 USD (2007-03-24 to 2008-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2887 The citation records this snapshot. The page link may show a newer release later.	USD 7.13 million Exact value Exact value: 7131000 USD 2007-03-24 – 2008-03-23: 7131000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2008-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 7131000 USD Concept: fundies:CapitalExpenditure Period: 2007-03-24 to 2008-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2008-03-23&surface=latest&period_type=duration&start=2007-03-24&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7131000 USD (2007-03-24 to 2008-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2962 The citation records this snapshot. The page link may show a newer release later.	−USD 12.69 million Calculation and evidence -5562000 − 7131000 USD Exact free cash flow: -12693000 USD 2007-03-24 – 2008-03-23: -5562000 USD · Inspect Operating Cash Flow · Source 2007-03-24 – 2008-03-23: 7131000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2008-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: -12693000 USD Concept: free-cash-flow Period: 2007-03-24 to 2008-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5562000 USD (2007-03-24 to 2008-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2887 Input fundies:CapitalExpenditure: 7131000 USD (2007-03-24 to 2008-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2962 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 741.18 million Exact value Exact value: -741176000 USD 2008-01-01 – 2008-12-31: -741176000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2008-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: -741176000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -741176000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#17863 The citation records this snapshot. The page link may show a newer release later.	−USD 38.01 million Exact value Exact value: -38007000 USD 2008-01-01 – 2008-12-31: -38007000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2008-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: -38007000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38007000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18143 The citation records this snapshot. The page link may show a newer release later.	USD 7.67 million Exact value Exact value: 7669000 USD 2008-01-01 – 2008-12-31: 7669000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2008-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 7669000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7669000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18199 The citation records this snapshot. The page link may show a newer release later.	−USD 45.68 million Calculation and evidence -38007000 − 7669000 USD Exact free cash flow: -45676000 USD 2008-01-01 – 2008-12-31: -38007000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 7669000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2008-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: -45676000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38007000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18143 Input fundies:CapitalExpenditure: 7669000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18199 The citation records this snapshot. The page link may show a newer release later.
2009 2008-03-14 – 2009-03-13	−USD 741.18 million Exact value Exact value: -741176000 USD 2008-03-14 – 2009-03-13: -741176000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2009-03-13 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: -741176000 USD Concept: fundies:NetIncome Period: 2008-03-14 to 2009-03-13 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2009-03-13&surface=latest&period_type=duration&start=2008-03-14&unit=USD&dimensions= Input fundies:NetIncome: -741176000 USD (2008-03-14 to 2009-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34259 The citation records this snapshot. The page link may show a newer release later.	−USD 38.01 million Exact value Exact value: -38007000 USD 2008-03-14 – 2009-03-13: -38007000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2009-03-13 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: -38007000 USD Concept: fundies:OperatingCashFlow Period: 2008-03-14 to 2009-03-13 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2009-03-13&surface=latest&period_type=duration&start=2008-03-14&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38007000 USD (2008-03-14 to 2009-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34487 The citation records this snapshot. The page link may show a newer release later.	USD 7.67 million Exact value Exact value: 7669000 USD 2008-03-14 – 2009-03-13: 7669000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2009-03-13 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 7669000 USD Concept: fundies:CapitalExpenditure Period: 2008-03-14 to 2009-03-13 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2009-03-13&surface=latest&period_type=duration&start=2008-03-14&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7669000 USD (2008-03-14 to 2009-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34562 The citation records this snapshot. The page link may show a newer release later.	−USD 45.68 million Calculation and evidence -38007000 − 7669000 USD Exact free cash flow: -45676000 USD 2008-03-14 – 2009-03-13: -38007000 USD · Inspect Operating Cash Flow · Source 2008-03-14 – 2009-03-13: 7669000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2009-03-13 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: -45676000 USD Concept: free-cash-flow Period: 2008-03-14 to 2009-03-13 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38007000 USD (2008-03-14 to 2009-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34487 Input fundies:CapitalExpenditure: 7669000 USD (2008-03-14 to 2009-03-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000230.txt#34562 The citation records this snapshot. The page link may show a newer release later.
2009 2008-03-24 – 2009-03-23	−USD 741.18 million Exact value Exact value: -741176000 USD 2008-03-24 – 2009-03-23: -741176000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2009-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: -741176000 USD Concept: fundies:NetIncome Period: 2008-03-24 to 2009-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2009-03-23&surface=latest&period_type=duration&start=2008-03-24&unit=USD&dimensions= Input fundies:NetIncome: -741176000 USD (2008-03-24 to 2009-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2659 The citation records this snapshot. The page link may show a newer release later.	−USD 38.01 million Exact value Exact value: -38007000 USD 2008-03-24 – 2009-03-23: -38007000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2009-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: -38007000 USD Concept: fundies:OperatingCashFlow Period: 2008-03-24 to 2009-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2009-03-23&surface=latest&period_type=duration&start=2008-03-24&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38007000 USD (2008-03-24 to 2009-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2887 The citation records this snapshot. The page link may show a newer release later.	USD 7.67 million Exact value Exact value: 7669000 USD 2008-03-24 – 2009-03-23: 7669000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2009-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 7669000 USD Concept: fundies:CapitalExpenditure Period: 2008-03-24 to 2009-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2009-03-23&surface=latest&period_type=duration&start=2008-03-24&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7669000 USD (2008-03-24 to 2009-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2962 The citation records this snapshot. The page link may show a newer release later.	−USD 45.68 million Calculation and evidence -38007000 − 7669000 USD Exact free cash flow: -45676000 USD 2008-03-24 – 2009-03-23: -38007000 USD · Inspect Operating Cash Flow · Source 2008-03-24 – 2009-03-23: 7669000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2009-03-23 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: -45676000 USD Concept: free-cash-flow Period: 2008-03-24 to 2009-03-23 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38007000 USD (2008-03-24 to 2009-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2887 Input fundies:CapitalExpenditure: 7669000 USD (2008-03-24 to 2009-03-23) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001176256-09-000252.txt#2962 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 22.87 million Exact value Exact value: -22868000 USD 2009-01-01 – 2009-12-31: -22868000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2009-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: -22868000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22868000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#17863 The citation records this snapshot. The page link may show a newer release later.	USD 21.97 million Exact value Exact value: 21971000 USD 2009-01-01 – 2009-12-31: 21971000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2009-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: 21971000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 21971000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18143 The citation records this snapshot. The page link may show a newer release later.	USD 4.37 million Exact value Exact value: 4366000 USD 2009-01-01 – 2009-12-31: 4366000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2009-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 4366000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4366000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18199 The citation records this snapshot. The page link may show a newer release later.	USD 17.61 million Calculation and evidence 21971000 − 4366000 USD Exact free cash flow: 17605000 USD 2009-01-01 – 2009-12-31: 21971000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 4366000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2009-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: 17605000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 21971000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18143 Input fundies:CapitalExpenditure: 4366000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18199 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 66.81 million Exact value Exact value: -66811000 USD 2010-01-01 – 2010-12-31: -66811000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANGIOTECH PHARMACEUTICALS INC · 2010-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Net Income: -66811000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -66811000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#17863 The citation records this snapshot. The page link may show a newer release later.	−USD 21.61 million Exact value Exact value: -21609000 USD 2010-01-01 – 2010-12-31: -21609000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2010-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: -21609000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21609000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18143 The citation records this snapshot. The page link may show a newer release later.	USD 5.73 million Exact value Exact value: 5726000 USD 2010-01-01 – 2010-12-31: 5726000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2010-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 5726000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5726000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18199 The citation records this snapshot. The page link may show a newer release later.	−USD 27.34 million Calculation and evidence -21609000 − 5726000 USD Exact free cash flow: -27335000 USD 2010-01-01 – 2010-12-31: -21609000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 5726000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2010-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: -27335000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21609000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18143 Input fundies:CapitalExpenditure: 5726000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/0001193125-11-068867.txt#18199 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	Unavailable Not reported for this period.	USD 66.43 million Exact value Exact value: 66432000 USD 2012-01-01 – 2012-12-31: 66432000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANGIOTECH PHARMACEUTICALS INC · 2012-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Operating Cash Flow: 66432000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 66432000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/000110465913025472/anpi-20121231.xml#297822 Filing: 000110465913025472 The citation records this snapshot. The page link may show a newer release later.	USD 2.12 million Exact value Exact value: 2115000 USD 2012-01-01 – 2012-12-31: 2115000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANGIOTECH PHARMACEUTICALS INC · 2012-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Capital Expenditure: 2115000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2115000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/000110465913025472/anpi-20121231.xml#5326507 Filing: 000110465913025472 The citation records this snapshot. The page link may show a newer release later.	USD 64.32 million Calculation and evidence 66432000 − 2115000 USD Exact free cash flow: 64317000 USD 2012-01-01 – 2012-12-31: 66432000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 2115000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANGIOTECH PHARMACEUTICALS INC · 2012-12-31 ANGIOTECH PHARMACEUTICALS INC (edgar:1096481) Free cash flow: 64317000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:19:04Z Snapshot: b7d193c0463d46b491bfa931d0352539f80b4ec5b03839243a384fbd42392e48 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1096481?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 66432000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/000110465913025472/anpi-20121231.xml#297822 Filing: 000110465913025472 Input fundies:CapitalExpenditure: 2115000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1096481/000110465913025472/anpi-20121231.xml#5326507 Filing: 000110465913025472 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

32 filings · 541 latest values · 541 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001096481, 1096481, edgar:1096481

Also known as ANGIOTECH PHARMACEUTICALS INC

ANGIOTECH PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation